230 related articles for article (PubMed ID: 33276151)
1. Epidemiology of bone metastases.
Ryan C; Stoltzfus KC; Horn S; Chen H; Louie AV; Lehrer EJ; Trifiletti DM; Fox EJ; Abraham JA; Zaorsky NG
Bone; 2022 May; 158():115783. PubMed ID: 33276151
[TBL] [Abstract][Full Text] [Related]
2. The effect of distant metastases sites on survival in de novo stage-IV breast cancer: A SEER database analysis.
Wu SG; Li H; Tang LY; Sun JY; Zhang WW; Li FY; Chen YX; He ZY
Tumour Biol; 2017 Jun; 39(6):1010428317705082. PubMed ID: 28653887
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of Site-Specific Metastases and Surgery in De Novo Stage IV Triple-Negative Breast Cancer: A Population-Based Analysis.
Gu Y; Wu G; Zou X; Huang P; Yi L
Med Sci Monit; 2020 Feb; 26():e920432. PubMed ID: 32043484
[TBL] [Abstract][Full Text] [Related]
4. Racial/ethnic disparities in de novo metastases sites and survival outcomes for patients with primary breast, colorectal, and prostate cancer.
Akinyemiju T; Sakhuja S; Waterbor J; Pisu M; Altekruse SF
Cancer Med; 2018 Apr; 7(4):1183-1193. PubMed ID: 29479835
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of the Site of Distant Metastasis and Surgical Interventions in Metastatic Gastric Cancer: A Population-Based Study.
Li Y; Xie D; Chen X; Hu T; Lu S; Han Y
Technol Cancer Res Treat; 2020; 19():1533033820964131. PubMed ID: 33111644
[TBL] [Abstract][Full Text] [Related]
6. Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States.
Hernandez RK; Wade SW; Reich A; Pirolli M; Liede A; Lyman GH
BMC Cancer; 2018 Jan; 18(1):44. PubMed ID: 29306325
[TBL] [Abstract][Full Text] [Related]
7. Regional Lymph Node Involvement Is Associated With Poorer Survivorship in Patients With Chondrosarcoma: A SEER Analysis.
Wan L; Tu C; Li S; Li Z
Clin Orthop Relat Res; 2019 Nov; 477(11):2508-2518. PubMed ID: 31283732
[TBL] [Abstract][Full Text] [Related]
8. De novo metastasis in breast cancer: occurrence and overall survival stratified by molecular subtype.
Press DJ; Miller ME; Liederbach E; Yao K; Huo D
Clin Exp Metastasis; 2017 Dec; 34(8):457-465. PubMed ID: 29288366
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a nomogram to predict survival outcome among epithelial ovarian cancer patients with site-distant metastases: a population-based study.
Wang B; Wang S; Ren W
BMC Cancer; 2021 May; 21(1):609. PubMed ID: 34034697
[TBL] [Abstract][Full Text] [Related]
10. Lung cancer with bone metastases in the United States: an analysis from the Surveillance, Epidemiologic, and End Results database.
Liu W; Wu J
Clin Exp Metastasis; 2018 Dec; 35(8):753-761. PubMed ID: 30341554
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Significance of Sites of Visceral Metastatic Disease in Prostate Cancer: A Population-based Study of 12,180 Patients.
Budnik J; Suri J; Bates JE; Bylund KC; Milano MT
Clin Genitourin Cancer; 2019 Aug; 17(4):260-267. PubMed ID: 31101579
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.
Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Decker M; Abdel-Rahman O
World J Gastroenterol; 2017 Mar; 23(10):1872-1880. PubMed ID: 28348494
[TBL] [Abstract][Full Text] [Related]
13. Synovial Sarcoma Is Not Associated With a Higher Risk of Lymph Node Metastasis Compared With Other Soft Tissue Sarcomas.
Jacobs AJ; Morris CD; Levin AS
Clin Orthop Relat Res; 2018 Mar; 476(3):589-598. PubMed ID: 29529647
[TBL] [Abstract][Full Text] [Related]
14. The prognosis of different distant metastases pattern in prostate cancer: A population based retrospective study.
Shou J; Zhang Q; Wang S; Zhang D
Prostate; 2018 May; 78(7):491-497. PubMed ID: 29436722
[TBL] [Abstract][Full Text] [Related]
15. Incidence and risk factors of gastrointestinal neuroendocrine neoplasm metastasis in liver, lung, bone, and brain: A population-based study.
Zheng Z; Chen C; Jiang L; Zhou X; Dai X; Song Y; Li Y
Cancer Med; 2019 Dec; 8(17):7288-7298. PubMed ID: 31609098
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and prognosis of bone metastases in common solid cancers at initial diagnosis: a population-based study.
Zhang J; Cai D; Hong S
BMJ Open; 2023 Oct; 13(10):e069908. PubMed ID: 37865405
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer bone metastases at initial diagnosis: a SEER-based study.
Li X; Zhang X; Liu J; Shen Y
BMC Cancer; 2020 Nov; 20(1):1102. PubMed ID: 33187507
[TBL] [Abstract][Full Text] [Related]
18. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
Milano AF
J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
[TBL] [Abstract][Full Text] [Related]
19. Population-based validation of the National Cancer Comprehensive Network recommendations for breast cancer staging.
Abdel-Rahman O
Breast Cancer Res Treat; 2018 Nov; 172(1):231-238. PubMed ID: 30022329
[TBL] [Abstract][Full Text] [Related]
20. The Epidemiology of Lung Metastases.
Chen H; Stoltzfus KC; Lehrer EJ; Horn SR; Siva S; Trifiletti DM; Meng MB; Verma V; Louie AV; Zaorsky NG
Front Med (Lausanne); 2021; 8():723396. PubMed ID: 34616754
[No Abstract] [Full Text] [Related]
[Next] [New Search]
